New Frontiers: Research Advances for High-Risk and Advanced Prostate Cancer
Beyond imaging and genetic testing, several distinct lines of research reported in 2026 are reshaping how doctors think about high-risk […]
The Genetic Turn: PARP Inhibitors Move Earlier in Prostate Cancer Treatment
One of the most consequential developments in prostate cancer research this year has nothing to do with a new drug […]
Seeing and Striking the Target: How PSMA Is Transforming Prostate Cancer Care
Prostate cancer research in 2026 has been defined by a single molecule: PSMA, or prostate-specific membrane antigen. This protein sits […]
July 2026
Includes: Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity, picnic and awareness events in July,